Evidence map›Paper›PMID 35774902›Full record

ArticleHealth psychology research2022

Managing anxiety disorders with the neuro-biofeedback method of Brain Boy Universal Professional.

Eleftheria Zafeiri, Vasileios Dedes, Kostantinos Tzirogiannis, Agapi Kandylaki, Maria Polikandrioti, Dimitris Panidis, Georgios I Panoutsopoulos

Open access · goldAbstract read
In one paragraph

Article in Health psychology research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Galvanic Skin Response Features in Psychiatry and Mental Disorders: A Narrative Review.International journal of environmental research and public health · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Eleftheria ZafeiriDepartment of Nursing, University of Peloponnese.
Vasileios DedesDepartment of Nursing, University of Peloponnese.
Kostantinos TzirogiannisDepartment of Nursing, University of Peloponnese.
Agapi KandylakiDepartment of Social Work, Democritus University of Thrace.
Maria PolikandriotiDepartment of Nursing, University of West Attica.
Dimitris PanidisDepartment of Nursing, University of Peloponnese.
Georgios I PanoutsopoulosDepartment of Nutritional Science and Dietetics, University of Peloponnese.ORCID 0000-0002-5442-8200
University of Peloponnese · GRDemocritus University of Thrace · GRUniversity of West Attica · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Biofeedback is a non-invasive therapeutic method used independently or as an adjunct alongside other methods. Objective: This study evaluated the efficacy of biofeedback in the treatment of anxiety disorders. Methods: The sample consisted of 85 individuals with anxiety symptoms who underwent neuro-biofeedback therapy using Brain Boy Universal Professional. Anxiety was assessed by both the Hamilton Rating Scale for Anxiety (HAM-A) and Zung Anxiety Self-Assessment Scale (SAS) before the initiation and after completing ten sessions with biofeedback. Results: Before biofeedback and based on the HAM-A scale, 27.0% of the individuals showed mild to moderate anxiety, 16.5% medium anxiety, and 56.5% severe anxiety. After the completion of biofeedback, 90.6% of the individuals experienced mild to moderate anxiety, 5.9% medium anxiety, and 3.5% severe anxiety. Based on the SAS scale, before biofeedback, 42.4% of the individuals showed minimal to moderate anxiety, 21.2% marked severe anxiety and 36.5% most extreme anxiety. After the biofeedback, 68.2% of the individuals were within a normal range, 27.1% had minimal to moderate anxiety, 4.7% marked severe anxiety, and none in most extreme anxiety. Conclusion: Both HAMA-A and SAS scales showed statistically reduced anxiety levels after biofeedback therapy. Thus, the primary symptom of anxiety can be addressed by the biofeedback method.

Indexed as

anxietyanxiety disordersbiofeedbackneuro-biofeedbackstress

Identifiers

PMID35774902
PMCPMC9239376
OpenAlexW4281684183

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.